NYSEAMERICAN:BVX Bovie Medical (BVX) Stock Price, News & Analysis → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free BVX Stock Alerts $6.48 +0.07 (+1.09%) (As of 12/31/2018) Add Compare Share Share Today's Range$6.35▼$6.7150-Day Range N/A52-Week Range$2.28▼$7.70Volume129,500 shsAverage Volume136,878 shsMarket Capitalization$215.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bovie Medical alerts: Email Address Ad The Bull ReportHealthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.Click here to see why this small company is trusted by the Mayo Clinic About Bovie Medical Stock (NYSEAMERICAN:BVX)Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.Read More BVX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BVX Stock News HeadlinesMay 10, 2024 | americanbankingnews.comBovie Medical (NYSEAMERICAN:BVX) Shares Pass Above 50 Day Moving Average of $0.00April 21, 2023 | marketwatch.com2023-2030 Medical Smoke Evacuation System Market Size with [113 Pages] includes Recent Developments | New Report by Absolute ReportsMarch 17, 2023 | markets.businessinsider.comBovie Medical earnings: here's what Wall Street expectsJanuary 22, 2023 | finance.yahoo.comElectrosurgical Devices Global Market Report 2022: Featuring Olympus, Bovie Medical, ATMOS, Johnson and Johnson & MoreJanuary 11, 2023 | thestreet.comBovie Medical Corporation (BVX): Today's Featured Health Care LoserOctober 16, 2022 | washingtonpost.comMEDICAL MYSTERIESOctober 26, 2021 | finance.yahoo.comBovie Medical (BVX) Looks Good: Stock Moves 9.1% HigherSee More Headlines Receive BVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bovie Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/01/2018Today5/16/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolNYSEAMERICAN:BVX Previous SymbolAMEX:BVX CUSIPN/A CIK719135 Webwww.boviemedical.com Phone(727) 384-2323FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares33,200,000Free FloatN/AMarket Cap$215.14 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesCharles D. GoodwinPresident, Chief Executive Officer & DirectorMatthew C. HillChief Financial & Accounting OfficerShawn D. RomanDirector-Research & DevelopmentKari LarsonSenior Director-Clinical AffairsTodd HornsbyExecutive Vice PresidentKey CompetitorsVeruNASDAQ:VERUWerewolf TherapeuticsNASDAQ:HOWLInnate PharmaNASDAQ:IPHAP3 Health PartnersNASDAQ:PIIIOptheaNASDAQ:OPTView All Competitors BVX Stock Analysis - Frequently Asked Questions How were Bovie Medical's earnings last quarter? Bovie Medical Co. (NYSEAMERICAN:BVX) announced its earnings results on Thursday, November, 1st. The medical device company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.08. The medical device company earned $3.67 million during the quarter, compared to the consensus estimate of $3.67 million. The business's revenue for the quarter was up 38.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.09) earnings per share. What other stocks do shareholders of Bovie Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bovie Medical investors own include Geron (GERN), AbbVie (ABBV), ENGlobal (ENG), Airgain (AIRG), Liquidity Services (LQDT), A.H. Belo (AHC), AMAG Pharmaceuticals (AMAG), Antares Pharma (ATRS), Ceragon Networks (CRNT) and Genetic Technologies (GENE). How do I buy shares of Bovie Medical? Shares of BVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:BVX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bovie Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.